During the 14th Annual Biomarkers Congress, 21-22 February 2019, Manchester, UK, Intertek experts will present on performance assessments for multiplex biomarker assays
The use of biomarkers to drive insight whilst assessing the efficacy, safety, and mechanism of action of drug products will be a key topic discussed at the 14th Annual Biomarkers Congress. As the pharmaceutical industry focuses on achieving increasingly more efficient and successful drug development through informed decision making, meet our experts during 14th Annual Biomarkers Congress to discuss how Intertek can support your biomarker assay development, validation and biomarker studies. Contact us to arrange a meeting during the event.
Meet Our Expert
Dr Tony Upton is the Laboratory Director for Bioanalysis Services at Intertek's Centre of Excellence in Biologics based in Manchester, UK. He has more than 17 years of industry experience conducting analysis in a regulatory environment and he specializes in immunoassays, in addition to applying his experience across the diverse range of analytical platforms at Intertek. Anthony was awarded a BSc in biochemistry and a Ph.D. in immunology from the University of Sheffield in the UK. He is a current member of the European Bioanalysis Forum community.
Our Biomarker and Bioanalysis Expertise
Our biomarker services provide fit-for-purpose validations in support of exploratory biomarkers based on your product requirements and full validation for confirmatory biomarkers where clinical decisions are being made to understand the drug’s efficacy and safety profile. Intertek utilises a diverse array of analytical platforms to support biomarker analysis including ELISA, flow cytometry, cell-based assays and ECL multiplex platforms.
We also provide bioanalytical pharmacokinetic and immunogenicity analysis for pre-clinical and clinical studies. Our GMP and CMC support programs include biologic product characterization packages, method development and validation, impurities analysis, stability, batch release and cell based potency testing. We apply our experience and depth of industry knowledge to help you to navigate the challenges of new product development, scale-up, manufacturing, bioanalysis and market release to meet regulatory expectations
More About the 14th Annual Biomarkers Congress
From the 21st to 22nd February 2019, over 350 delegates from pharmaceutical and biotech organisations, CROs and academia will meet in Manchester, UK, to discuss the latest developments in biomarker applications, methods, best practice and regulatory considerations.
Need help or have a question?